Manual Implantation of Full-Thickness Skin Microcolumns
2 other identifiers
interventional
10
0 countries
N/A
Brief Summary
The objective of this study is to validate the proof of concept regarding the approach of manual implantation of full-thickness skin microcolumns (FTSMs) as coverage for open wounds without creating an additional donor scar and while also capitalizing on the wound healing benefits offered by full-thickness skin grafts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 20, 2021
CompletedFirst Posted
Study publicly available on registry
February 4, 2022
CompletedStudy Start
First participant enrolled
November 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 29, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 29, 2025
CompletedOctober 18, 2024
October 1, 2024
11 months
October 20, 2021
October 17, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Donor site re-epithelization between day 10 to 14
Donor site re-epithelization between day 10 to 14
10-14 days
Secondary Outcomes (2)
Donor site
up to 6 months
Injured site
up to 6 months
Study Arms (1)
Full-thickness skin microcolumns Implantation
EXPERIMENTALimplantation of FTSM on open wound
Interventions
Surgical harvest and implantation of FTSM on an open wound requiring coverage.
Eligibility Criteria
You may qualify if:
- years of age
- cm2 open wound on the scalp, neck, torso or extremities necessitating tissue coverage
- Sufficiently healthy skin to serve as a donor site
You may not qualify if:
- Wound area involving the face\*
- Wound area involving joints\*
- Pregnancy
- Prisoner
- Active wound infection at potential treatment sites
- Exposed muscle, joint, tendon, or bone within the wound bed
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rodney Chan, MD
Metis Foundation
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 20, 2021
First Posted
February 4, 2022
Study Start
November 4, 2024
Primary Completion
September 29, 2025
Study Completion
September 29, 2025
Last Updated
October 18, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share